A review links Lebanon's refugee-era disease burden to housing, not borders

Lebanon hosts one of the highest per-capita refugee populations in the world, and its public-health system has absorbed that load through more than a decade of economic crisis. A systematic review published in Public Health on 30 April sets out what the peer-reviewed record says about infectious disease in that context — and is careful about where it assigns cause [s1].

What the review examined

The authors searched PubMed and Scopus for English-language studies from 2013 to 2024 on infectious disease in Lebanon reported in the context of the Syrian crisis, following PRISMA methodology [s1]. Of 211 articles identified, 22 met the inclusion criteria and were synthesised narratively [s1]. That is a small evidence base, and the review is a synthesis of it rather than a new measurement — a limit the reader should hold onto.

The diseases named

The review reports an increased burden across a long list of infections affecting both Syrian refugees and the Lebanese population: tuberculosis, measles, mumps, leishmaniasis, hepatitis A, cholera, scabies, human lice infestation, rabies, polio, echinococcosis, amebiasis and salmonellosis [s1]. Several of these are vaccine-preventable or water-borne — the categories that respond to sanitation and immunisation rather than to clinical treatment alone.

The list is worth reading as a diagnosis of conditions rather than a roll-call of pathogens. Cholera, hepatitis A, amebiasis and salmonellosis are transmitted through contaminated water and food, and their appearance points to failures in water and sanitation. Measles, mumps and polio are vaccine-preventable, and their presence points to gaps in immunisation coverage. Scabies and lice are diseases of crowding. Tuberculosis thrives where people live close together and healthcare is hard to reach. Each cluster names a specific, addressable failure — which is the review's implicit argument that the burden is a function of circumstances that policy can change.

Where the review locates the cause

The most important feature of the review is what it identifies as the drivers. It names overcrowded and unsanitary living conditions, limited healthcare access, and economic constraints as the factors most frequently reported [s1]. The framing matters: the burden is attributed to conditions — housing, water, sanitation, access — rather than to the movement of people as such. That distinction is the difference between a public-health problem with public-health solutions and a political claim, and the review stays on the public-health side of it.

A concrete data point

One primary study illustrates the vaccine-preventable angle at the level of a single camp. Published in New Microbes and New Infections on 9 June, it surveyed 84 Palestinian refugees attending a hospital in the Al-Baddawi camp in North Lebanon between December 2023 and May 2024 [s2]. It found 78.6% were seropositive for total anti-hepatitis A antibodies — reflecting accumulated immunity from prior infection or vaccination — while 2.4% tested positive for IgM, indicating limited recent or acute infection at the time [s2]. Reported vaccination coverage was high, with 96.4% saying they had received at least one dose, and those aged 16 to 30 were at higher risk of seropositivity (P < 0.05) [s2].

This is a small, single-site study of a different refugee population — Palestinian rather than Syrian — so it cannot be read as representative of Lebanon or of refugees generally. What it adds is a measured snapshot: high past exposure or vaccination against hepatitis A, and little acute infection detected in that particular camp at that time.

What it establishes

Read together, the two studies describe a health system under strain in which infectious disease risk tracks living conditions and access to care. The systematic review's evidence base is thin and its conclusions are qualitative; the camp study is small. Neither supports a precise national figure. What they support is the review's central recommendation — that strengthening healthcare infrastructure, disease surveillance, targeted vaccination, and access to care for all residents, including undocumented migrants, is the route to reducing the burden [s1].

The point about undocumented migrants is a practical one rather than a political stance. Infectious disease does not distinguish between documented and undocumented residents, and a surveillance or vaccination programme that leaves part of the population outside it leaves a reservoir in which transmission continues. That is why the review frames access for everyone as a public-health requirement, and why it calls for international cooperation and sustained investment rather than one-off interventions [s1]. The evidence it rests on is limited — 22 studies over a decade — so its strongest claim is directional: the burden rose, it rose fastest where conditions were worst, and the remedies lie in conditions and access rather than in any single clinical measure [s1].